Equity Overview
Price & Market Data
Price: $5.87
Daily Change: -$0.05 / 0.85%
Range: $5.85 - $6.06
Market Cap: $228,062,416
Volume: 48,735
Performance Metrics
1 Week: -2.73%
1 Month: -34.12%
3 Months: -45.70%
6 Months: -39.30%
1 Year: -44.62%
YTD: -26.63%
Company Details
Employees: 183.6
Sector: Health technology
Industry: Medical specialties
Country: Belgium
Details
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.